CCG
AGN

Ceeto Capital Group’s Allergan plc AGN Stock Holding History

Ceeto Capital Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$177K – 136
2020
Q1 		$177K Sell
1,000
-1,000
-50% -$188K 0.14% 117
2019
Q4 		$382K Hold
2,000
– – 0.25% 97
2019
Q3 		$337K Sell
2,000
-6,000
-75% -$978K 0.24% 103
2019
Q2 		$1.34M Hold
8,000
– – 0.99% 32
2019
Q1 		$1.17M Hold
8,000
– – 0.86% 40
2018
Q4 		$1.07M Hold
8,000
– – 0.88% 39
2018
Q3 		$1.52M Hold
8,000
– – 1.05% 24
2018
Q2 		$1.33M Hold
8,000
– – 1% 27
2018
Q1 		$1.35M Hold
8,000
– – 1.02% 28
2017
Q4 		$1.31M Buy
8,000
+2,000
+33% +$359K 0.93% 35
2017
Q3 		$1.23M Buy
+6,000
New +$1.4M 0.92% 34

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ceeto Capital Group's AGN Position: Q2 2020 in Review

Ceeto Capital Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,000 shares — an estimated $177K sold.

Ceeto Capital Group first reported a position in AGN in Q3 2017 and held it in 11 quarters. The position peaked at $1.52M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ceeto Capital Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ceeto Capital Group sold 1,000 Allergan plc shares in Q2 2020, an estimated $177K.
  • Ceeto Capital Group first reported a position in Allergan plc in Q3 2017 and held it in 11 quarters.
  • Ceeto Capital Group's Allergan plc position peaked at $1.52M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ceeto Capital Group's 13F filing for Q2 2020, filed 11 Aug 2020.